JP2023526567A5 - - Google Patents
Info
- Publication number
- JP2023526567A5 JP2023526567A5 JP2023513266A JP2023513266A JP2023526567A5 JP 2023526567 A5 JP2023526567 A5 JP 2023526567A5 JP 2023513266 A JP2023513266 A JP 2023513266A JP 2023513266 A JP2023513266 A JP 2023513266A JP 2023526567 A5 JP2023526567 A5 JP 2023526567A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- alkyl
- alkoxy
- hydrogen
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063022479P | 2020-05-09 | 2020-05-09 | |
| US63/022,479 | 2020-05-09 | ||
| US202063053056P | 2020-07-17 | 2020-07-17 | |
| US63/053,056 | 2020-07-17 | ||
| PCT/US2021/031282 WO2021231208A1 (en) | 2020-05-09 | 2021-05-07 | Methods of treating covid-19 using bardoxolone methyl or analogs thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026078603A Division JP2026129953A (ja) | 2020-05-09 | 2026-05-08 | バルドキソロンメチルまたはそのアナログを用いてｃｏｖｉｄ－１９を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526567A JP2023526567A (ja) | 2023-06-21 |
| JP2023526567A5 true JP2023526567A5 (enExample) | 2024-05-16 |
Family
ID=76197607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513266A Pending JP2023526567A (ja) | 2020-05-09 | 2021-05-07 | バルドキソロンメチルまたはそのアナログを用いてｃｏｖｉｄ－１９を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230255982A1 (enExample) |
| EP (1) | EP4146226A1 (enExample) |
| JP (1) | JP2023526567A (enExample) |
| KR (1) | KR20230022164A (enExample) |
| CN (1) | CN115803059B (enExample) |
| AU (1) | AU2021273460A1 (enExample) |
| BR (1) | BR112022022599A2 (enExample) |
| CA (1) | CA3177913A1 (enExample) |
| IL (1) | IL298008A (enExample) |
| MX (1) | MX2022014034A (enExample) |
| WO (1) | WO2021231208A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL285832B2 (en) * | 2013-08-23 | 2024-01-01 | Reata Pharmaceuticals Inc | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof |
| CA3240963A1 (en) * | 2021-12-23 | 2023-06-29 | Steven Laplante | Drug combinations for inhibiting coronavirus replication |
| WO2023170187A1 (en) * | 2022-03-09 | 2023-09-14 | Technische Universität München | INHIBITION OF INTRACELLULAR PATHOGEN UPTAKE BY INHIBITORS OF THE IKK-α/NIK COMPLEX |
| CN116509874A (zh) * | 2023-02-01 | 2023-08-01 | 潍坊医学院附属医院 | 甲基巴多索隆在制备改善病毒性心肌炎或病毒性心肌损伤的药物中的用途 |
| CN118903154B (zh) * | 2024-08-22 | 2025-11-11 | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 化合物CDDO-Im用于预防或治疗口蹄疫的新用途 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| AU1772992A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Crosstalk inhibitors and their uses |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| GB9212302D0 (en) | 1992-06-10 | 1992-07-22 | Applied Research Systems | Method for improving measurement precision in evanescent wave optical biosensor assays |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| DK1465615T3 (da) | 2002-01-15 | 2012-11-12 | Dartmouth College | Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf |
| EP2094651A1 (en) | 2006-11-17 | 2009-09-02 | Trustees Of Dartmouth College | Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| JP5570415B2 (ja) | 2007-05-08 | 2014-08-13 | アボット・ラボラトリーズ | 他のペプチド型に対する交差反応性の低いヒトｂ型ナトリウム利尿ペプチドアッセイ |
| US8088824B2 (en) | 2007-08-15 | 2012-01-03 | Reata Pharmaceuticals Inc. | Forms of CDDO methyl ester |
| KR100905466B1 (ko) | 2007-10-08 | 2009-07-02 | 한국과학기술원 | 차세대 셀룰라 통신시스템에서의 중계 통신방법 |
| ME03529B (me) | 2008-01-11 | 2020-04-20 | Reata Pharmaceuticals Inc | Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti |
| US8071632B2 (en) | 2008-04-18 | 2011-12-06 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: novel derivatives of oleanolic acid |
| RS58392B1 (sr) | 2008-04-18 | 2019-04-30 | Reata Pharmaceuticals Inc | Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17 |
| TW201006474A (en) | 2008-04-18 | 2010-02-16 | Reata Pharmaceuticals Inc | Natural products including an anti-flammatory pharmacore and methods of use |
| EP2279197B1 (en) | 2008-04-18 | 2014-11-05 | Reata Pharmaceuticals, Inc. | Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring |
| HUE033288T2 (en) | 2008-04-18 | 2017-11-28 | Reata Pharmaceuticals Inc | Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives |
| SG173601A1 (en) | 2009-02-13 | 2011-09-29 | Reata Pharmaceuticals Inc | Delayed release, oral dosage compositions that contain amorphous cddo-me |
| AU2011240690C1 (en) * | 2010-04-12 | 2014-11-06 | Reata Pharmaceuticals Holdings, LLC | Method of treating obesity using antioxidant inflammation modulators |
| CN102875634B (zh) | 2012-10-24 | 2014-08-20 | 苏州晶云药物科技有限公司 | 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型 |
| CN102887936A (zh) | 2012-10-24 | 2013-01-23 | 苏州晶云药物科技有限公司 | 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯晶型 |
| IL285832B2 (en) * | 2013-08-23 | 2024-01-01 | Reata Pharmaceuticals Inc | Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof |
| BR112019009256A2 (pt) * | 2016-11-08 | 2019-07-16 | Reata Pharmaceuticals, Inc. | métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo |
| WO2019014412A1 (en) | 2017-07-13 | 2019-01-17 | Pliva Hrvatska D.O.O. | NOVEL CRYSTALLINE POLYMORPHIC FORMS OF METHYL BARDOXOLONE |
| WO2021202547A1 (en) * | 2020-04-01 | 2021-10-07 | Triterpenoid Therapeutics, Inc. | Methods and compositions for treating and preventing viral infection |
| WO2021202245A1 (en) * | 2020-04-02 | 2021-10-07 | Egaceutical Corporation | Viral treatment regimens |
-
2021
- 2021-05-07 CA CA3177913A patent/CA3177913A1/en active Pending
- 2021-05-07 KR KR1020227041044A patent/KR20230022164A/ko active Pending
- 2021-05-07 CN CN202180046645.7A patent/CN115803059B/zh active Active
- 2021-05-07 EP EP21729131.9A patent/EP4146226A1/en active Pending
- 2021-05-07 MX MX2022014034A patent/MX2022014034A/es unknown
- 2021-05-07 US US17/998,291 patent/US20230255982A1/en active Pending
- 2021-05-07 JP JP2023513266A patent/JP2023526567A/ja active Pending
- 2021-05-07 AU AU2021273460A patent/AU2021273460A1/en active Pending
- 2021-05-07 IL IL298008A patent/IL298008A/en unknown
- 2021-05-07 WO PCT/US2021/031282 patent/WO2021231208A1/en not_active Ceased
- 2021-05-07 BR BR112022022599A patent/BR112022022599A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240100005A1 (en) | Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases | |
| JP5869469B2 (ja) | 鉄が病因に関与する肝臓疾患の処置 | |
| JP2004522714A5 (enExample) | ||
| JP2011148806A (ja) | 重症心不全の治療方法およびその薬剤 | |
| WO2008070547A1 (en) | Improved acyclovir formulations | |
| WO2022218958A1 (en) | Combination comprising everolimus and amcenestrant | |
| EP3937944B1 (en) | Toll-like receptor agonists for use in the treatment of hepatitis b | |
| JP2024507788A5 (enExample) | ||
| JP2025013684A (ja) | 重度腎機能障害を有する癌患者に対する治療方法 | |
| TW202617156A (zh) | 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法 | |
| JP2022533981A5 (enExample) | ||
| CN112121044B (zh) | 氨来占诺用于制备抗肝炎病毒药物的用途 | |
| Lithell et al. | Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study | |
| CN113194945A (zh) | 环吡酮的抑制hbv核心组装的用途 | |
| CN121443295A (zh) | 治疗前列腺癌的方法 | |
| CN115105501A (zh) | 西奥罗尼用于小细胞肺癌的治疗 | |
| AU2021221333B2 (en) | Novel medicament for treating inflammatory disease | |
| EP3999069B1 (en) | Synergistic effect of eyp001 and pegylated ifn-alpha for the treatment of hbv infection | |
| JP3885135B2 (ja) | Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤 | |
| CN106619591B (zh) | 奥昔卡因在制备药物中的用途及药物组合物 | |
| JP3944257B2 (ja) | 肝実質細胞増殖因子産生増加剤 | |
| JP4426654B2 (ja) | 免疫調節用医薬組成物 | |
| JP2020520904A5 (enExample) | ||
| EP4190329A1 (en) | Cold remedy and antiviral agent | |
| JP2003081843A (ja) | 有機ゲルマニウム化合物を有効成分とするｉｉ型糖尿病性腎症の発症予防又は治療剤。 |